Risk of Suicide After Cancer Diagnosis in England

Background—Although stroke and ischemic heart disease (IHD) have several well-established risk factors in common, the extent of global variation in the relative burdens of these forms of vascular disease and reasons for any observed variation are poorly understood. Methods and Results—We analyzed mortality and disability-adjusted life-year loss rates from stroke and IHD, as well as national estimates of vascular risk factors that have been developed by the World Health Organization Burden of Disease Program. National income data were derived from World Bank estimates. We used linear regression for univariable analysis and the Cuzick test for trends. Among 192 World Health Organization member countries, stroke mortality rates exceeded IHD rates in 74 countries (39%), and stroke disability-adjusted life-year loss rates exceeded IHD rates in 62 countries (32%). Stroke mortality ranged from 12.7% higher to 27.2% lower than IHD, and stroke disability-adjusted life-year loss rates ranged from 6.2% higher to 10.2% lower than IHD. Stroke burden was disproportionately higher in China, Africa, and South America, whereas IHD burden was higher in the Middle East, North America, Australia, and much of Europe. Lower national income was associated with higher relative mortality (P 0.001) and burden of disease (P 0.001) from stroke. Diabetes mellitus prevalence and mean serum cholesterol were each associated with greater relative burdens from IHD even after adjustment for national income. Conclusions—There is substantial global variation in the relative burden of stroke compared with IHD. The disproportionate burden from stroke for many lower-income countries suggests that distinct interventions may be required. (Circulation. 2011; 124:314-323.)

[1]  INTERNATIONAL LIST OF CAUSES OF DEATH , 1927, British medical journal.

[2]  Essai d'une statistique comparative de la morbidité devant servir a établir les listes spéciales des causes de morbidité , 1928 .

[3]  G. H. Knibbs,et al.  The International Classification of Disease and Causes of Death and its Revision. , 1929 .

[4]  Manual for Coding Causes of Illness According to a Diagnosis Code for Tabulating Morbidity Statistics , 1946 .

[5]  M. Greenwood,et al.  Medical Statistics from Graunt to Farr. , 1950 .

[6]  H. Dorn,et al.  Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. Vol. I , 1950 .

[7]  I. Moriyama The eighth revision of the International Classification of Diseases. , 1966, American journal of public health and the nation's health.

[8]  C. C. Spicer Manual of the International Statistical Classification of Diseases Injuries, and Causes of Death--Volume 1. , 1969 .

[9]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.

[10]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[11]  F. Jones,et al.  International Classification of Diseases , 1978 .

[12]  Lay reporting of health information. , 1981 .

[13]  Daniel B Hier,et al.  Race, sex and occlusive cerebrovascular disease: a review. , 1986, Stroke.

[14]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[15]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.

[16]  A. Dobson,et al.  Confidence intervals for weighted sums of Poisson parameters. , 1991, Statistics in medicine.

[17]  Z. Bankowski,et al.  Council for International Organizations of Medical Sciences , 1991 .

[18]  I. Lauder,et al.  Pattern of Cerebral Atherosclerosis in Hong Kong Chinese: Severity in Intracranial and Extracranial Vessels , 1993, Stroke.

[19]  B. Ford International Classification of Impairments, Disabilities and Handicaps , 1984, Releve epidemiologique hebdomadaire.

[20]  K. Smith,et al.  Breast cancer mortality among immigrants in Australia and Canada. , 1995, Journal of the National Cancer Institute.

[21]  R. Marks,et al.  Squamous cell carcinoma , 1996, The Lancet.

[22]  O. Gefeller,et al.  An alternative approach to monitoring cancer patient survival , 1996 .

[23]  D. M. Parkin,et al.  Risk of cancer in migrants and their descendants in Israel: II. Carcinomas and germ‐cell tumours , 1997, International journal of cancer.

[24]  D. Parkin,et al.  Interpretation of population-based cancer survival data. , 1998, IARC scientific publications.

[25]  S. Yusuf,et al.  Emerging epidemic of cardiovascular disease in developing countries. , 1999, Circulation.

[26]  M. Coory,et al.  Cancer among people living in rural and remote Indigenous communities in Queensland , 2000, The Medical journal of Australia.

[27]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[28]  S. Yusuf,et al.  Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.

[29]  I. Jacobs,et al.  Ovarian cancer screening in the general population: current status , 2001, International Journal of Gynecologic Cancer.

[30]  Alan D. Lopez,et al.  The burden of disease and injury in Australia. , 2001, Bulletin of the World Health Organization.

[31]  A. Omran,et al.  The epidemiologic transition. A theory of the Epidemiology of population change. 1971. , 2001, Bulletin of the World Health Organization.

[32]  G. Giles,et al.  Ovarian cancer: patterns of care in Victoria during 1993–1995 , 2002, The Medical journal of Australia.

[33]  H. Brenner,et al.  On crude and age-adjusted relative survival rates. , 2003, Journal of clinical epidemiology.

[34]  Jan J Barendregt,et al.  A generic model for the assessment of disease epidemiology: the computational basis of DisMod II , 2003, Population health metrics.

[35]  J. Tuomilehto,et al.  Are Changes in Mortality From Stroke Caused by Changes in Stroke Event Rates or Case Fatality?: Results From the WHO MONICA Project , 2003, Stroke.

[36]  M. Kubo,et al.  Trends in the Incidence, Mortality, and Survival Rate of Cardiovascular Disease in a Japanese Community: The Hisayama Study , 2003, Stroke.

[37]  Maristela Monteiro,et al.  The Global Distribution of Average Volume of Alcohol Consumption and Patterns of Drinking , 2003, European Addiction Research.

[38]  K. Reddy,et al.  Cardiovascular disease in non-Western countries. , 2004, The New England journal of medicine.

[39]  G. Vlastos,et al.  Poorer survival of elderly patients with ovarian cancer: a population-based study. , 2004, Surgical oncology.

[40]  H. Brenner,et al.  An alternative approach to age adjustment of cancer survival rates. , 2004, European journal of cancer.

[41]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[42]  Catherine Quantin,et al.  Comparison of Cox's and relative survival models when estimating the effects of prognostic factors on disease‐specific mortality: a simulation study under proportional excess hazards , 2005, Statistics in medicine.

[43]  F. Bray,et al.  Ovarian cancer in Europe: Cross‐sectional trends in incidence and mortality in 28 countries, 1953–2000 , 2005, International journal of cancer.

[44]  T. Gaziano,et al.  Cardiovascular Disease in the Developing World and Its Cost-Effective Management , 2005, Circulation.

[45]  M. Mcmurdo,et al.  Including older people in clinical research , 2005, BMJ : British Medical Journal.

[46]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[47]  Alan D. Lopez,et al.  The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001 -- Global Burden of Disease and Risk Factors , 2006 .

[48]  Hys Ngan,et al.  Carcinoma of the Ovary , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[49]  J. Berek,et al.  Ovarian cancer in younger vs older women: a population-based analysis , 2006, British Journal of Cancer.

[50]  T. Gaziano Reducing the growing burden of cardiovascular disease in the developing world. , 2007, Health affairs.

[51]  R. Beaglehole,et al.  Stroke prevention in poor countries: time for action. , 2007, Stroke.

[52]  C. Mathers,et al.  Preventing stroke: saving lives around the world , 2007, The Lancet Neurology.

[53]  C. Warlow,et al.  Burden of stroke in black populations in sub-Saharan Africa , 2007, The Lancet Neurology.

[54]  Maurizio Pisati,et al.  SPMAP: Stata module to visualize spatial data , 2007 .

[55]  V. Fuster,et al.  Low Priority of Cardiovascular and Chronic Diseases on the Global Health Agenda: A Cause for Concern , 2007, Circulation.

[56]  Ming Liu,et al.  Stroke in China: epidemiology, prevention, and management strategies , 2007, The Lancet Neurology.

[57]  E. Riboli,et al.  The second expert report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective , 2007 .

[58]  S. Pecorelli,et al.  History of the FIGO cancer staging system , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[59]  L. Holmberg,et al.  Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer , 2008, International journal of cancer.

[60]  L. Goldman,et al.  The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China , 2008, BMC public health.

[61]  E. Weiderpass,et al.  Predictors of ovarian cancer survival: A population‐based prospective study in Sweden , 2008, International journal of cancer.

[62]  Makoto Watanabe,et al.  Cardiovascular Disease and Risk Factors in Asia: A Selected Review , 2008, Circulation.

[63]  S. Leung,et al.  Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies , 2008, PLoS medicine.

[64]  D. Roder,et al.  Reasons for Improved Survival From Ovarian Cancer in New South Wales, Australia, Between 1980 and 2003: Implications for Cancer Control , 2009, International Journal of Gynecologic Cancer.

[65]  S Claiborne Johnston,et al.  Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling , 2009, The Lancet Neurology.

[66]  La atención a la salud en Brasil a partir de la percepción de travestis, transexuales y transgéneros , 2009 .

[67]  J. Motmans,et al.  Being transgender in Belgium: mapping the social and legal situation of transgender people , 2010 .

[68]  Chronic Disease Division Cancer facts and figures , 2010 .

[69]  J. Grant,et al.  Injustice at Every Turn: A Report of the National Transgender Discrimination Survey , 2011 .

[70]  D. V. Dyke Squamous cell cancer , 2011 .

[71]  J. S. Hutta,et al.  Transrespect versus Transphobia Worldwide : A Comparative Review of the Human-rights Situation of Gender-variant/Trans People , 2012 .

[72]  S. Winter Lost in transition: transgender people,. Rights and HIV vulnerability in the Asia-Pacific region , 2012 .

[73]  S. Keuzenkamp Worden wie je bent. Het leven van transgenders in Nederland , 2012 .

[74]  Yan Guo,et al.  Australian classification of health interventions: ACHI: tabular list of interventions , 2013 .

[75]  Anne M Elsworthy,et al.  Australian coding standards for ICD-10-AM and ACHI , 2013 .

[76]  LONDON: HER MAJESTY'S STATIONERY OFFICE , 2022 .